Clinical profiles and outcomes in patients with ulcerative colitis receiving standard and higher-than-standard doses of vedolizumab: findings from a real-world study in Europe-Reference-Cited by-同舟云学术

Clinical profiles and outcomes in patients with ulcerative colitis receiving standard and higher-than-standard doses of vedolizumab: findings from a real-world study in Europe

Published:2023-08-28 Issue:9 Volume:39 Page:1205-1214
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Gisbert Javier P.¹,Streit Petra²,Redondo Isabel³,Hartz Susanne⁴,Knight Hannah⁵^ORCID,Quinones Emily⁵^ORCID,Harvey Niamh⁵^ORCID,Palace Vanda⁵^ORCID,Hunter Gibble Theresa⁶^ORCID

Affiliation:

1. Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain

2. Eli Lilly and Company, Vernier, Switzerland

3. Eli Lilly and Company, Lisbon, Portugal

4. Eli Lilly and Company, Bracknell, UK

5. Adelphi Real World, Bollington, UK

6. Eli Lilly and Company, Indianapolis, IN, USA

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2023.2244414

Reference36 articles.

1. Ulcerative colitis

2. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies

3. Ulcerative colitis

4. ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment

5. ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editor-in-Chief Foreword: can we engage in evidence-based medicine by using practice-based evidence?;Current Medical Research and Opinion;2023-12-02